共 329 条
[1]
Wang M(2021)The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway Cancer Lett 512 60-72
[2]
Dai M(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[3]
Wang D(2020)Triple-negative breast cancer molecular subtyping and treatment progress Breast Cancer Res 22 61-198
[4]
Tang T(2019)Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment Cancer Discov 9 176-1261
[5]
Xiong F(2020)Triplenegative breast cancer therapy: Current and future perspectives (Review) Int J Oncol 57 1245-489
[6]
Xiang B(2020)Role of immunotherapy in triple-negative breast cancer J Natl Compr Canc Netw 18 479-690
[7]
Zhou M(2016)Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease Nat Rev Clin Oncol 13 674-113
[8]
Li X(2022)Treatment landscape of triple-negative breast cancer - expanded options, evolving needs Nat Rev Clin Oncol 19 91-224
[9]
Li Y(2021)YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2 Cancer Biol Ther 22 216-2012
[10]
Xiong W(2021)LINC01234 aggravates cell growth and migration of triple-negative breast cancer by activating the Wnt pathway Environ Toxicol 36 1999-112